Last edition
News about "neurodegenerative disease "
Amneal Pharma Gets US FDA Approval for CREXONT Extended-Release Capsules
CREXONT is a novel, oral formulation of carbidopa/levodopa (CD/LD) that combines both immediate-release (IR) granules and extended-release (ER) pellets.
Neurodegenerative Disease | 08/08/2024 | By Aishwarya | 306
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members